Date of dispatch of this notice: 31/08/2021
Expire date: 30/09/2021
External Reference: 2021-265341
TED Reference: 2021/S 171-445820
Prior information notice
Information
Published
Prior information notice
Prior information notice
Services
Directive 2014/24/EU
This notice is for prior information only
Section I: Contracting authority
I.1)
Name and addresses
Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
Contact person:
Enda Caulfield
E-mail:
enda.caulfield@hse.ie
NUTS code:
IE -
IRELAND
Main address:
http://www.hse.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461
I.2)
Joint procurement
The contract is awarded by a central purchasing body
I.3)
Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at:
http://www.hse.ieAdditional information can be obtained from
the abovementioned address:
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
Provision of HPV primary screening and secondary screening by way of liquid-based cytology for CervicalCheck the national cervical screening programme in Ireland.
Reference number:
HSE 16917 CervicalCheck
II.1.2)
Main CPV code
71900000
-
Laboratory services
II.1.3)
Type of contract
Services
II.1.4)
Short description
The aim of CervicalCheck, the national cervical screening programme in Ireland, is to reduce morbidity and mortality in the population through early detection of high grade CIN. The programme screens around 250,000 women per year and this may rise to up to 300,000 people per year. Since its inception in 2008, CervicalCheck has provided almost 3.2 million cervical screening tests and detected over 115,000 cervical abnormalities. The programme has detected and treated 64,000 precancerous cell changes, many of which could have developed into cervical cancer if not detected through screening.
To support the delivery of this programme, the HSE wishes to notify the market of its intention to procure a suitably qualified laboratory provider(s) to provide HPV primary screening and secondary screening by way of liquid-based cytology. This is not a call for competition. A Contract Notice will issue in due course to commence the procurement process.
To support the delivery of this programme, the HSE wishes to notify the market of its intention to procure a suitably qualified laboratory provider(s) to provide HPV primary screening and secondary screening by way of liquid-based cytology. This is not a call for competition. A Contract Notice will issue in due course to commence the procurement process.
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2)
Description
II.2.2)
Additional CPV code(s)
85145000
-
Services provided by medical laboratories
II.2.3)
Place of performance
NUTS code:
IE -
IRELAND
Main site or place of performance:
Ireland
II.2.4)
Description of the procurement
To support the delivery of this programme, the HSE wishes to notify the market of its intention to procure a suitably qualified laboratory provider(s) to provide HPV primary screening and secondary screening by way of liquid-based cytology. This is not a call for competition. A Contract Notice will issue in due course to commence the procurement process.
II.3)
Estimated date of publication of contract notice:
01/11/2021
Section IV: Procedure
IV.1)
Description
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: yes
IV.2)